Objective: To assess the relationship between coronary heart disease (CHD) and menopausal symptoms in middle-aged women in Taiwan.
Patients And Methods: The present study identified 14,340 symptomatic menopausal women without a history of CHD from the Taiwan National Health Insurance Research Database from January 1, 2000, to December 31, 2013. A total of 14,340 age- and Charlson-comorbidity-index-score-matched asymptomatic women were used as controls. Possible comorbidity-attributable risks of CHD were surveyed to assess whether the symptomatic menopausal cohort had a higher incidence of CHD.
Results: The incidence of CHD was higher in the symptomatic menopausal cohort than in the control cohort (17.18 vs. 12.05 per 1000 person-years). After adjustment in multivariate Cox analysis, the risk of CHD was significantly higher in the symptomatic menopausal cohort (adjusted hazard ratio = 1.344, 95% confidence interval [CI] = 1.262-1.43, P < 0.001) than in the control cohort. In the symptomatic menopausal cohort, the risk of CHD was significantly higher in all subgroups, except for the hormone therapy (HT) subgroup. Patients undergoing HT had a nonsignificantly higher risk of CHD, regardless of the presence or absence of menopausal symptoms.
Conclusion: This large-scale longitudinal retrospective cohort study revealed that menopausal symptoms are an independent risk factor for CHD. Moreover, our findings indicate that HT has a nonsignificant effect on the risk of CHD.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193730 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0206036 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Clustering Iranian women according to their menopausal severity symptoms and exploring the factors associated with severe categories, using baseline category logit model.
BMC Womens Health
December 2024
Department of Epidemiology and Biostatistics, School of Health, Mashhad University of Medical sciences, Mashhad, Iran.
Article Synopsis
- * Researchers conducted a cross-sectional study with 664 women in Mashhad, using the Menopause Severity Symptoms Inventory (MSSI-38) to group women into three clusters based on their symptom severity: mild, moderate, and severe.
- * Results indicated that women in moderate and severe symptom clusters had significant associations with higher rates of underlying diseases, lack of physical activity, and more pregnancies, with the severe cluster being most affected by factors such as insufficient income and menopause stage.
Multicenter, prospective, single-arm clinical study to investigate the efficacy and safety of Zoladex (Goserelin acetate) 10.8 mg prior to surgery in Chinese premenopausal women with symptomatic uterine fibroids.
Gynecol Endocrinol
December 2024
The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Article Synopsis
- The study aimed to evaluate the effectiveness and safety of Goserelin acetate (Zoladex) 10.8 mg in patients with uterine fibroids, with assessments made before and after a 12-week treatment period, leading up to surgery.
- After treatment, significant reductions were observed in uterine and fibroid volumes, along with decreased levels of hormones like estrogen, while hemoglobin levels increased, indicating improved anemia symptoms.
- The results indicated that Goserelin acetate is both effective in managing uterine fibroids and safe, with a high incidence of adverse events but overall good tolerance reported among patients.
Case report of an unusual presentation of a urethral caruncle.
Int J Surg Case Rep
December 2024
Urology A Department, Ibn Sina Hospital, Rabat, Morocco.
Introduction: Urethral caruncle is a benign lesion located at the urethral meatus, predominantly affecting postmenopausal women. Though often asymptomatic, it can sometimes present with symptoms that significantly impact the patient's quality of life. Diagnosis is usually straightforward based on physical examination.
View Article and Find Full Text PDFDeciphering the influence of gut and oral microbiomes on menopause for healthy aging.
J Genet Genomics
November 2024
Beijing Key Laboratory for Genetics of Birth Defects, Beijing Pediatric Research Institute, MOE Key Laboratory of Major Diseases in Children, Rare Disease Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China. Electronic address:
Article Synopsis
- - Menopause is a natural part of aging marked by the end of menstruation and decreased reproductive function, yet it's often overlooked in women's health discussions.
- - The gut and oral microbiota play crucial roles in maintaining health and could significantly impact the aging experience for menopausal women, highlighting the need for more research in this area.
- - The study examines how the microbiome interacts with sex hormones and related diseases, suggesting that targeting the microbiome could lead to new treatments that improve menopausal symptoms and overall quality of life for women.
Experiences With Genitourinary Syndrome of Menopause and Barriers to Vaginal Estrogen Usage Reported by a National Sample of 1500 Women.
Urology
November 2024
The Section of Urology and Renal Transplantation, Virginia Mason Medical Center, Seattle, WA, 98101. Electronic address:
Objective: To investigate women's experiences with genitourinary syndrome of menopause (GSM) and vaginal estrogen therapy (VET), including barriers, awareness, and knowledge, and to report current trends and findings on GSM and VET to address barriers to care.
Methods: A survey on GSM and VET was posted on the ResearchMatch website. Eligible participants were women ≥ 40 years of age.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!